Colorectal cancer
Conditions
Interventions
Gold Standard:Clinical outcomes
Sponsors
Shanghai Cancer Center affiliated to Fudan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged from 18 to 80, regardless of gender; 2. Patients with liver metastasis of colorectal cancer confirmed by pathological diagnosis; 3. Patients with complete resection (R0) of primary colorectal cancer and liver metastases; 4. Patients whose postoperative general condition allows chemotherapy; 5. Patients whose expected survival time is more than 6 months; 6. There are enough surgical or biopsy specimens for gene detection; 7. The subjects (or their legal representative / Guardian) must sign the informed consent, indicating that they understand the purpose of the study, understand the necessary procedures of the study, and are willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with active bleeding of clinical significance; 2. Those who are addicted to alcohol or drugs; 3. Patients with important organ failure or other serious diseases, including clinical related coronary artery disease, cardiovascular disease or patients with myocardial infarction, congestive heart failure, unstable angina pectoris, symptomatic pericardial effusion or unstable arrhythmia within 6 months before enrollment; 4. Patients with severe neurological or psychiatric history; severe infection; active disseminated intravascular coagulation or other accompanying diseases that seriously endanger the safety of patients or affect the completion of the study according to the judgment of the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy; | — |
Secondary
| Measure | Time frame |
|---|---|
| accuracy on efficacy;overall survival;recurrence free survival; | — |
Countries
China
Contacts
Public ContactLu Wang
Shanghai Cancer Center affiliated to Fudan University
Outcome results
None listed